Cipmido 2.5mg Tablet
By Cipmido
Rx
20 Tablet in a Strip

Composition
Midodrine(2.5mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
April, 2026

liver
There is limited information about the safety of using Cipmido 2.5mg Tablet in patients with liver disease. It is important to consult your doctor before using this medication to ensure it is safe for you. Your doctor will be able to provide guidance on the use of Cipmido 2.5mg Tablet based on your specific liver condition.

kidney
There is limited information on using Cipmido 2.5mg Tablet for patients with kidney disease. Consult your doctor for guidance.

alcohol
It is uncertain if it is safe to consume alcohol while taking Cipmido 2.5mg Tablet. Consult your doctor for guidance.

driving
It is uncertain if Cipmido 2.5mg Tablet affects driving ability. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Cipmido 2.5mg Tablet may not be safe to use during pregnancy due to potential harmful effects on the developing baby. Limited human studies are available, but animal studies suggest caution. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor before use.

breastfeeding
Caution Cipmido 2.5mg Tablet may not be safe while breastfeeding, as it can pass into the breastmilk and potentially harm the baby.
Habit Forming | No |
Chemical Class | Ethanolamine Derivative |
Therapeutic Class | - |
Action Class | Alpha-1 adrenoreceptor agonists |
₹1045
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024